Adaptive Biotechnologies
Facts
- HQ
- Seattle
- Sectors
- Biotech, Immune medicine, Diagnostics
- Founded
- 2009 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Adaptive Biotechnologies Corporation Seattle business license
- Stage
- Public
Accolade exits GeekWire 200 after $220M IPO at $1.2B valuation; PNW health techs climb as VC funding hits $2.3B in H1 2020
GeekWire’s latest GeekWire 200 update shows health tech startups rising in the Pacific Northwest rankings during the pandemic, highlighted by Accolade’s $220M IPO at a $1.2B valuation and a surge in VC activity ($2.3B across 135 deals in H1 2020).
Accolade files IPO to sell 8.75M shares at $19–$21, seeks up to $211M and ~$1B valuation; will trade as ACCD
Accolade priced 8.75 million IPO shares at $19–$21 to raise up to $211 million, aiming for a ~ $1 billion valuation and Nasdaq ticker ACCD, positioning itself as Seattle's first public company of 2020. The health benefits platform reported $132.5 million revenue and a $51.3 million net loss for the fiscal year ending Feb. 29, serves 1.6 million members across 58 corporate customers, and estimates a $24 billion total addressable market.
Docugami doubles to 20 after $10M funding and keeps hiring amid widespread tech layoffs
Docugami, a Kirkland, Washington document-engineering startup, doubled its staff to 20 after a $10 million funding round in early February and continues hiring despite widespread tech layoffs. CEO Jean Paoli and new head of operations Hartley Riedner have onboarded remotely, reflecting a flipped labor market where some startups can recruit while larger firms cut jobs.
Inside the IPO: Adaptive Biotech
Chad Robins is a Cornell grad and Wharton School MBA who was working in real estate finance a decade ago when he was approached with a business idea by his brother, Harlan Robins, head of the Computational Biology Program at the Fred Hutchinson Cancer Research Center. As Chad Robins recalled, "When he called me up in 2009 and said, 'Hey I want to start a business, I've figured out how to sequence T-cells at a high throughput,' I was like, 'Yes, I'm in!' and then I went to Wikipedia and I'm like, 'What the hell is he talking about?' I…
Microsoft's giant health investment
Washington State is suing Motel 6 after the hotel chain shared customers' personal data with federal immigration authorities. Plus, Microsoft makes a big investment in an AI-fueled health test that could screen dozens of diseases at once. That and more on this episode of the Week In Geek. Follow all our coverage and read more about this week's stories at GeekWire.com See omnystudio.com/listener for privacy information.
